Otsuka Holdings Co., Ltd. (OTSKY) Financials
OTSKY Assets vs Liabilities
| Date | Assets | Liabilities |
|---|---|---|
| June 30, 2026 | 27.0 billion | 6.7 billion |
| March 31, 2026 | 26.5 billion | 6.5 billion |
| Dec. 31, 2025 | 26.8 billion | 7.0 billion |
| Sept. 30, 2025 | 27.2 billion | 7.1 billion |
OTSKY Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
| Date | Free Cash Flow | Stock based compensation |
|---|---|---|
| June 30, 2026 | 553.0 million | ? |
| March 31, 2026 | 533.8 million | ? |
| Dec. 31, 2025 | 396.1 million | ? |
| Sept. 30, 2025 | 615.0 million | ? |
OTSKY Net Income
Graph available only for paid members. Upgrade to see it.
| Date | Net Income |
|---|---|
| June 30, 2026 | 730.5 million |
| March 31, 2026 | 627.0 million |
| Dec. 31, 2025 | 425.6 million |
| Sept. 30, 2025 | 853.3 million |
OTSKY Cash and Debt
Graph available only for paid members. Upgrade to see it.
| Date | Cash | Debt | Capital Lease |
|---|---|---|---|
| June 30, 2026 | 3.1 billion | 536.5 million | 612.1 million |
| March 31, 2026 | 3.4 billion | 550.6 million | 486.6 million |
| Dec. 31, 2025 | 3.4 billion | 1.1 billion | 644.9 million |
| Sept. 30, 2025 | 3.4 billion | 592.5 million | 509.7 million |
OTSKY Shares Outstanding
OTSKY Expenses
Graph available only for paid members. Upgrade to see it.
| Date | Capex | R&D | G&A | S&M |
|---|---|---|---|---|
| June 30, 2026 | 123.5 million | 561.1 million | 1.7 billion | - |
| March 31, 2026 | 160.4 million | 523.4 million | 1.7 billion | - |
| Dec. 31, 2025 | 156.5 million | 677.1 million | 1.8 billion | - |
| Sept. 30, 2025 | 129.8 million | 589.5 million | 1.7 billion | - |
OTSKY Cost of Revenue
Graph available only for paid members. Upgrade to see it.
| Date | Revenue | Cost of Revenue |
|---|---|---|
| June 30, 2026 | 4.4 billion | 1.2 billion |
| March 31, 2026 | 4.0 billion | 1.1 billion |
| Dec. 31, 2025 | 4.2 billion | 1.3 billion |
| Sept. 30, 2025 | 4.4 billion | 1.2 billion |
OTSKY
Price: $39.59
52 week price:
Payout Ratio Range:
Earnings Per Share: 2.55 USD
P/E Ratio: 14.91
Exchange: PNK
Sector: Healthcare
Industry: Drug Manufacturers - General
Market Capitalization: 38.0 billion